E
Addex Therapeutics Ltd ADXN
$9.44 $0.525.83% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -205.73% 174.52% 164.32% 146.34% 133.19%
Total Depreciation and Amortization -31.94% 1,521.80% 1,554.20% 118.21% -18.66%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 122.13% -584.20% -580.07% -550.33% -532.41%
Change in Net Operating Assets 279.88% -241.95% -577.64% 98.54% 69.96%
Cash from Operations 86.91% 52.41% 31.84% 40.81% 23.99%
Capital Expenditure 31.82% 70.00% 80.52% 53.97% 63.93%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -100.45% -- -- -- 139,383.78%
Cash from Investing -100.48% 102,820.00% 66,801.30% 81,888.89% 215,045.83%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 97.25% 96.25% 73.85% 49.59% 24.05%
Issuance of Common Stock -98.38% -99.71% -89.77% -89.10% -93.72%
Repurchase of Common Stock 100.00% 47.47% 45.51% 59.31% 59.68%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 173.98% -97.98% -101.07% -101.13% -102.24%
Cash from Financing 168.60% -99.12% -97.90% -98.98% -101.51%
Foreign Exchange rate Adjustments 79.89% 93.75% 128.41% 60.60% 71.94%
Miscellaneous Cash Flow Adjustments -- 196.68% -- -- --
Net Change in Cash 72.12% 128.57% 80.16% 72.24% -136.13%